Performance of the Parent Report of Children's Abilities–Revised (PARCA-R) versus the Bayley Scales of Infant Development III

Martin, Andrew; Darlow, Brian A; Salt, Alison; Hague, Wendy; Sebastian, Lucille; McNeill, Nicki; Tarnow‐Mordi, William

doi:10.1136/archdischild-2012-303288

Cited by 42 publications

(42 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings are consistent with other studies of the PARCA-R at age two years (6,8,14) and the PARCA3 at three years (7) . Of particular importance is that a number of studies, which have been conducted on different populations and using different individuallyadministered tests, provide evidence of the convergent validity of using the PARCA together with a vocabulary questionnaire to assess cognitive development of preschool-aged children.…”

Section: Regression Analysessupporting

confidence: 83%

“…Both the PARCA-R and the PARCA3 comprise a parent questionnaire and parent-administered tasks. The PARCA-R displayed significant relationships with the Bayley Scales of Infant Development-II Mental Development Index (6) , and the Bayley-III Cognitive and Language composite at age two years (8) in children born full term. Further research suggests this instrument may act as a useful screening tool for at-risk populations such as children born pre-term.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Parent ratings of child cognition and language compared with Bayley-III in preterm 3-year-olds

Perra

McGowan

Grunau

et al. 2015

Early Human Development

View full text Add to dashboard Cite

show abstract

Section: Regression Analysessupporting

confidence: 83%

Section: Introductionmentioning

confidence: 99%

Parent ratings of child cognition and language compared with Bayley-III in preterm 3-year-olds

Perra

McGowan

Grunau

et al. 2015

Early Human Development

View full text Add to dashboard Cite

show abstract

“…Concurrent validity was confirmed with large correlations between PARCA-R PRC and Bayley scores. These correlations were of the same order of magnitude as found in previous studies [8][9][10][11][12] and exceed those of some other studies in which the validity of parent questionnaires of development have been assessed. 25,26 The results of this study thus give weight to previous studies demonstrating the validity of the PARCA-R in preterm populations.…”

Section: Discussionsupporting

confidence: 68%

“…11 Parents have the opportunity to observe their child in a variety of situations, but a test situation is timelimited and dependent on the current emotional and attentional state of the child, which may affect their performance. A structured assessment challenges all children in a similar way while parents vary in terms of whether they challenge their child' s full range of abilities with some avoiding situations their child may fail.…”

Section: Discussionmentioning

confidence: 99%

“…5,6 Because faceto-face follow-up is likely to be too costly for all LMPT children, first-line screening to identify a subgroup of children in need of a clinical review may be pragmatic and cost-effective. 7 The Parent Report of Children' s Abilities-Revised (PARCA-R), a parent questionnaire of cognitive and language development at 2 years of age, has excellent sensitivity and specificity for identifying neurodevelopmental delay among very preterm children and those with neonatal complications, [8][9][10][11][12] enabling its use as a clinical tool and outcome measure for randomized trials. 13,14 The PARCA-R may therefore be useful for developmental screening in children born LMPT, but its validity in this population has not been tested.…”

Section: (Continued On Last Page)mentioning

confidence: 99%

See 1 more Smart Citation

A Parent Questionnaire for Developmental Screening in Infants Born Late and Moderately Preterm

et al. 2014

View full text Add to dashboard Cite

BACKGROUND: The Parent Report of Children’s Abilities-Revised (PARCA-R) is a questionnaire for assessing cognitive and language development in very preterm infants. Given the increased risk of developmental delay in infants born late and moderately preterm (LMPT; 32–36 weeks), this study aimed to validate this questionnaire as a screening tool in this population. METHODS: Parents of 219 children born LMPT completed the PARCA-R questionnaire and the Brief Infant Toddler Social and Emotional Assessment when children were 24 months corrected age (range, 24 months–27 months). The children were subsequently assessed by using the cognitive and language scales of the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). RESULTS: An average Bayley-III, cognitive and language (CB-III) score and a total PARCA-R Parent Report Composite (PRC) score were computed. There was a large association between PRC and CB-III scores (r = 0.66, P < .001) indicating good concurrent validity. Using Youden index, the optimum PARCA-R cutoff for identifying children with moderate/severe developmental delay (CB-III scores < 80) was PRC scores < 73. This gave sensitivity 0.90 (95% confidence interval: 0.75–1.00) and specificity 0.76 (95% confidence interval: 0.70–0.82), indicating good diagnostic utility. Approximately two-thirds of the children who had a PRC score < 73 had false-positive screens. However, these children had significantly poorer cognitive and behavioral outcomes than children with true negative screens. CONCLUSIONS: The PARCA-R has good concurrent validity with a gold standard developmental test and can be used to identify LMPT infants who may benefit from a clinical assessment. The PARCA-R has potential for clinical use as a first-line cognitive screening tool for this sizeable population of infants in whom follow-up may be beneficial.

show abstract

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Dargaville

Kamlin

Orsini

et al. 2023

JAMA

Self Cite

View full text Add to dashboard Cite

ImportanceThe long-term effects of surfactant administration via a thin catheter (minimally invasive surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome remain to be definitively clarified.ObjectiveTo examine the effect of MIST on death or neurodevelopmental disability (NDD) at 2 years’ corrected age.Design, Setting, and ParticipantsFollow-up study of a randomized clinical trial with blinding of clinicians and outcome assessors conducted in 33 tertiary-level neonatal intensive care units in 11 countries. The trial included 486 infants with a gestational age of 25 to 28 weeks supported with continuous positive airway pressure (CPAP). Collection of follow-up data at 2 years’ corrected age was completed on December 9, 2022.InterventionsInfants assigned to MIST (n = 242) received exogenous surfactant (200 mg/kg poractant alfa) via a thin catheter; those assigned to the control group (n = 244) received sham treatment.Main Outcomes and MeasuresThe key secondary outcome of death or moderate to severe NDD was assessed at 2 years’ corrected age. Other secondary outcomes included components of this composite outcome, as well as hospitalizations for respiratory illness and parent-reported wheezing or breathing difficulty in the first 2 years.ResultsAmong the 486 infants randomized, 453 had follow-up data available (median gestation, 27.3 weeks; 228 females [50.3%]); data on the key secondary outcome were available in 434 infants. Death or NDD occurred in 78 infants (36.3%) in the MIST group and 79 (36.1%) in the control group (risk difference, 0% [95% CI, −7.6% to 7.7%]; relative risk [RR], 1.0 [95% CI, 0.81-1.24]); components of this outcome did not differ significantly between groups. Secondary respiratory outcomes favored the MIST group. Hospitalization with respiratory illness occurred in 49 infants (25.1%) in the MIST group vs 78 (38.2%) in the control group (RR, 0.66 [95% CI, 0.54-0.81]) and parent-reported wheezing or breathing difficulty in 73 (40.6%) vs 104 (53.6%), respectively (RR, 0.76 [95% CI, 0.63-0.90]).Conclusions and RelevanceIn this follow-up study of a randomized clinical trial of preterm infants with respiratory distress syndrome supported with CPAP, MIST compared with sham treatment did not reduce the incidence of death or NDD by 2 years of age. However, infants who received MIST had lower rates of adverse respiratory outcomes during their first 2 years of life.Trial Registrationanzctr.org.au Identifier: ACTRN12611000916943

show abstract

Performance of the Parent Report of Children's Abilities–Revised (PARCA-R) versus the Bayley Scales of Infant Development III

Abstract: The results support the PARCA-R as a practical tool for the identification of appreciable cognitive and language delay at 24 months among critically ill premature and extremely low birthweight neonates.

Cited by 42 publications

References 14 publications

Parent ratings of child cognition and language compared with Bayley-III in preterm 3-year-olds

Parent ratings of child cognition and language compared with Bayley-III in preterm 3-year-olds

A Parent Questionnaire for Developmental Screening in Infants Born Late and Moderately Preterm

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

Contact Info

Product

Resources

About